BenevolentAI secures $2bn valuation after raising $115mn in funding

By Jonathan Dyble
BenevolentAI, a leading British artificial intelligence company, has been valued at more than $2bn following its latest funding round where the company...

BenevolentAI, a leading British artificial intelligence company, has been valued at more than $2bn following its latest funding round where the company secured $115mn in financing.

BenevolentAI is working to use AI as a way of discovering new medicines and treatments for difficult and stubborn diseases. Within the pharmaceutical industry, Benevolent AI is the only company using AI as a means to discover and develop clinical capabilities.

See also:

“We are very pleased with the response to the fundraising,” said Ken Mulvany, Founder and Chairman of BenevolentAI. “It reflects the rapidly growing global interest in the AI pharmaceutical sector and the recognition of our place as the dominant player within it.”

The company’s current drug development portfolio has proven that it can cut drug discovery by up to four years and deliver increased efficiencies of 60% in the development process compared to the averages displayed in the pharmaceutical industry. For an industry that spends $180bn on research and development annually, this technology offers significant potential.

“The capabilities of our technology didn't exist six years ago,” Mulvany continued. “We are pioneering this sector and have evolved into a fully integrated, AI enabled drug development company with the ability to deliver better medicines at previously unimaginable speeds - this ultimately means patients will receive the right medicines, at a lower cost, in less time.”

The funds raised will be used to help the company diversify its offerings into a number of different industries such as the energy storage, manufacturing and agricultural sectors, alongside bolstering its current use in pharmaceuticals.

Share

Featured Articles

Qlik's Julie Kae: Leveraging Data to Improve Sustainability

In an exclusive interview with Qlik’s Julie Kae, she explores siloed data business challenges and how leveraging data can improve sustainability strategies

Study: More than Half of Companies Lack AI Innovation Skills

Research by SoftwareOne reveals a stark human skills gap in maximising AI and cloud potential, as 97% of companies prioritise upskilling workforces

Devoteam Expands into UK Market, Acquires Ubertas Consulting

Devoteam acquires cloud business and AWS consultancy, Ubertas Consulting, to deliver AWS services to a broader client base and expand into UK markets

NTT DATA: Outdated Tech Holding Back Global Organisations

Digital Transformation

CGG Rebrands to Viridien to Become an Advanced Tech Company

Cloud & Cybersecurity

Zoom Invests in UK Market with Immersive Experience Centre

Digital Transformation